BIOFARMA

ABREAL

scientific, optical, weighing, measuring, signaling, checking, supervision, life-saving and teaching apparatus and instruments, namely, computers, microscopes for scientific or research purposes in the fields of neuropsychiatric diseases, immune-inflammatory diseases, cardiovascular diseases, diabetes and cancers; apparatus for recording, transmission or reproduction of sound or images; computers; software recorded on magnetic media or downloaded from a remote computer network for controlling and managing patient medical information; personal digital assistant; transmitters of electronic signals; video cameras; activity sensors, namely, wearable activity trackers; downloadable applications for mobile devices to enable users to track their symptoms, physical activity and vital signs and to record and share information with healthcare professionals; spectacles; contact lenses; virtual reality helmets;business management assistance services; database management; compilation of mathematical or statistical data; computer file management; compilation of information in computer databases; updating and maintenance of data in computer databases; business management and organization consultancy; business management consultancy; market research studies; information relating to market research; commercial intermediary services in the context of linking potential private investors with entrepreneurs looking for financing; expertise in business productivity, namely, business consulting in the field of business productivity; sales promotion services for others; public relations; sponsorship search; auctioneering services; organization of events for commercial or advertising purposes; providing of personnel, namely, personnel placement; collection of business information in the nature of market research information;providing of individual support services to families of patients with serious illnesses; online social networking services;medical services; veterinary services; hygienic and beauty care for human beings or animals; advisory services relating to health; telemedicine services; therapeutic services; medical diagnosis services; Home health care services; individualized medical prescription refill reminder services; online medical prescription services, namely, interactive medical monitoring and alert service for reminding clients of medicinal dosage, allergy sensitivity, and prescription refills for medical treatment purposes; consultancy in relation to medical treatment in the home; advice relating to self-medication; provision of medical information to patients; remote medical examination services; medical monitoring of patients including remote monitoring; providing medical support in the monitoring of patients receiving medical treatments;medical, apparatus, instruments and equipment, namely, medical devices for monitoring vital signs, blood properties and respiratory events; artificial teeth, eyes, organs and limbs; orthopedic supports; suture material; medical compression stockings, tights and socks; medical stockings, tights and socks for varicose veins; syringes for medical use; medical measuring instruments, namely, instruments able to directly transmit data to a database in the nature of fever measuring instruments and heart rate monitors; nanorobots for medical use; medical devices intended for ingestion; endoscopic video capsules; medical apparatus for measuring biochemical changes in blood; inhalers for medical use; blood pressure monitors;

ACEON

The mark is amended to appear as follows: PUBLISH NEW CUT;In the statement, Column 1, Line 2, Simplifee is deleted, and, Simplifiee is inserted. In the statement, Column 1, Line 2 through 3, Not provided Societe Par Actions Simplifiee is deleted.;In the statement, Column 1, Line 1, (Societe Par Actions Simplifee) is deleted, and, In the statement, Column 1, Line 2, Not Provided is deleted, and, France is inserted.;Pharmaceuticals, namely, a prescription cardiovascular preparation for inhibiting angiotensin converting enzyme;In the statement, Column 1, Line 2, Simpifiee is deleted, and, Simplifiee is inserted.;

ACEON

In the statement, Column 1, Line 1, SOCIETE PAR ACTIONS SIMPLIFEE is deleted, and, SOCIÉTÉ PAR ACTIONS SIMPLIFIÉE is inserted.;Pharmaceuticals, namely, a prescription cardio-vascular preparation for inhibiting angiotensin converting enzyme;

ACEON

The mark consists of the word ACEON with two rings to the left.;Pharmaceutical, namely, a prescription cardiovascular preparation for inhibiting angiotensin converting enzyme;The mark was first used in commerce in a different form other than that sought to be registered at least as early as 08/00/1999.;The mark was first used anywhere in a different form other than that sought to be registered at least as early as 08/00/1999.;Color is not claimed as a feature of the mark.;